ZHEJIANG BENLI TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.08 CNY | +0.39% |
|
-3.52% | -20.53% |
| Sales 2022 | 76Cr 10Cr 870.01Cr | Sales 2023 | 70Cr 9.64Cr 800.24Cr | Capitalization | 241.2Cr 33Cr 2.77TCr |
|---|---|---|---|---|---|
| Net income 2022 | 5.9Cr 81.47L 68Cr | Net income 2023 | 5.9Cr 81.47L 68Cr | EV / Sales 2022 | 2.14 x |
| Net cash position 2022 | 55Cr 7.63Cr 633.35Cr | Net cash position 2023 | 57Cr 7.86Cr 652.8Cr | EV / Sales 2023 | 2.64 x |
| P/E ratio 2022 |
36.6
x | P/E ratio 2023 |
40.6
x | Employees | 589 |
| Yield 2022 |
0.49% | Yield 2023 |
0.44% | Free-Float | 33.89% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.39% | ||
| 1 week | -3.52% | ||
| Current month | -5.98% | ||
| 1 month | +4.51% | ||
| 3 months | +8.52% | ||
| 6 months | -25.38% | ||
| Current year | -20.53% |
1 week
17.94
19.25
1 month
17.2820.40
Current year
11.8123.41
1 year
11.8124.84
3 years
11.8175.33
5 years
11.8175.33
10 years
11.8175.33
| Managers | Title | Age | Since |
|---|---|---|---|
Zheng Jie Wu
CEO | Chief Executive Officer | 60 | 01/12/01 |
Chao Yang Pan
DFI | Director of Finance/CFO | 60 | 01/14/01 |
Yong Sun
BRD | Director/Board Member | 57 | 26/15/26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xin Jian Zhao
BRD | Director/Board Member | 69 | 15/22/15 |
Liu Yi Chen
BRD | Director/Board Member | 63 | 01/19/01 |
Zheng Jie Wu
CEO | Chief Executive Officer | 60 | 01/12/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/24/24 | 18.08 | +0.39% | 534,550 |
| 23/24/23 | 18.01 | -2.38% | 727,000 |
| 22/24/22 | 18.45 | -1.07% | 661,350 |
| 21/24/21 | 18.65 | -2.71% | 692,700 |
| 20/24/20 | 19.17 | +2.29% | 1,193,753 |
End-of-day quote Shenzhen S.E., May 24, 2024
More quotes
Zhejiang Benli Technology Co Ltd is a company engaged in the research and development (R&D), production and sales of pharmaceutical intermediates, pesticide intermediates and new material intermediates. The Company's products mainly include 801 products, 1201 products, 1501 products and 1701 products. The Company's products are mainly used in quinolone active pharmaceutical ingredients (APIs), pesticides, fungicides, pesticides, herbicides, photoinitiators, pharmaceutical cephalosporins and other fields. The Company's products have been exported to foreign markets such as India and Japan.
Sector
Pharmaceuticals
Calendar
07/06/2024
- Extraordinary Shareholders Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -20.53% | 26Cr | |
| +38.51% | 73TCr | |
| +33.05% | 60TCr | |
| -6.23% | 35TCr | |
| +18.78% | 33TCr | |
| +1.35% | 28TCr | |
| +16.00% | 24TCr | |
| +8.09% | 20TCr | |
| -5.77% | 20TCr | |
| +6.19% | 16TCr |
- Stock Market
- Equities
- 301065 Stock
